The Progressive Co. (NYSE:PGR – Free Report) – Research analysts at Zacks Research increased their Q2 2024 earnings estimates for Progressive in a research report issued to clients and investors on Wednesday, April 10th. Zacks Research analyst T. De now anticipates that the insurance provider will post earnings of $1.75 per share for the quarter, […]

Accenture plc (NYSE:ACN – Free Report) – Research analysts at Zacks Research lowered their Q3 2024 earnings per share estimates for Accenture in a note issued to investors on Wednesday, April 10th. Zacks Research analyst R. Department now forecasts that the information technology services provider will post earnings per share of $3.07 for the quarter, […]

Walker & Dunlop, Inc. (NYSE:WD – Free Report) – Investment analysts at Wedbush dropped their Q2 2024 earnings estimates for Walker & Dunlop in a research note issued to investors on Thursday, April 11th. Wedbush analyst J. Mccanless now expects that the financial services provider will post earnings of $0.77 per share for the quarter, […]

Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Leerink Partnrs increased their Q1 2024 earnings estimates for shares of Sage Therapeutics in a research report issued on Tuesday, April 9th. Leerink Partnrs analyst M. Goodman now expects that the biopharmaceutical company will earn ($1.64) per share for the quarter, up from their previous […]

Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Analysts at Leerink Partnrs issued their Q2 2024 earnings per share (EPS) estimates for Stoke Therapeutics in a research note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst R. Li forecasts that the company will post earnings per share of ($0.43) for the quarter. The […]

CrossFirst Bankshares (NASDAQ:CFB – Get Free Report) will be posting its quarterly earnings results after the market closes on Monday, April 15th. Analysts expect CrossFirst Bankshares to post earnings of $0.34 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link. CrossFirst Bankshares […]

Savaria (TSE:SIS – Free Report) had its price target boosted by Desjardins from C$22.50 to C$23.50 in a research note published on Wednesday, BayStreet.CA reports. The firm currently has a buy rating on the stock. Desjardins also issued estimates for Savaria’s Q2 2024 earnings at $0.70 EPS, Q3 2024 earnings at $0.20 EPS, FY2024 earnings […]

Savaria (TSE:SIS – Free Report) had its price target boosted by Desjardins from C$22.50 to C$23.50 in a research note published on Wednesday, BayStreet.CA reports. The firm currently has a buy rating on the stock. Desjardins also issued estimates for Savaria’s Q2 2024 earnings at $0.70 EPS, Q3 2024 earnings at $0.20 EPS, FY2024 earnings […]